Katharina Leucht

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Peritoneal Dialysis

Metastatic Renal Cell Carcinoma

Top Venues

Journal of clinical medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Klara Franke, Susan Foller, Michele Estephania Rosero Moreno, Nalyan Ali, Lutz Leistritz, Katharina Leucht, Marc-Oliver Grimm
Reasonability of Frequent Laboratory Analyses during Therapy with Nivolumab and Nivolumab+Ipilimumab in Patients with Advanced or Metastatic Renal Cell Carcinoma during the Phase 2 Clinical Trial TITAN-RCC. Cancers 16 (12) (2024)
Klara Franke, Susan Foller, Michele Estephania Rosero Moreno, Nalyan Ali, Lutz Leistritz, Katharina Leucht, Marc-Oliver Grimm
Reasonability of Frequent Laboratory Analyses during Therapy with Nivolumab and Nivolumab+Ipilimumab in Patients with Advanced or Metastatic Renal Cell Carcinoma during the Phase 2 Clinical Trial TITAN-RCC. Cancers 16 (12) (2024)
Marc-Oliver Grimm, Bernd Jürgen Schmitz-Dräger, Uwe Zimmermann, Christine Barbara Grün, Gustavo Bruno Baretton, Marc Schmitz, Susan Foller, Katharina Leucht, Martin Schostak, Friedemann Zengerling, Ulrike Schumacher, Wolfgang Loidl, Johannes Meran
Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Katharina Leucht, Nalyan Ali, Susan Foller, Marc-Oliver Grimm
Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma. Cancers 14 (18) (2022)
Marc-Oliver Grimm, Katharina Leucht, Susan Foller
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma. Journal of clinical medicine 10 (22) (2021)